Ameritas Investment Partners, Inc. Cassava Sciences Inc Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 3,951 shares of SAVA stock, worth $10,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,951
Previous 3,951
-0.0%
Holding current value
$10,904
Previous $116,000
92.24%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SAVA
# of Institutions
190Shares Held
16.4MCall Options Held
3.49MPut Options Held
8.08M-
Black Rock Inc. New York, NY3.22MShares$8.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$6.94 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.78 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$2.75 Million0.0% of portfolio
-
Ubs Group Ag931KShares$2.57 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $111M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...